LAURA SERTICH: Open Payments
NPI 1457819948 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 42 payments from 23 companies in 2025. Trend: 2023 $466 · 2024 $1,204 · 2025 $982
Food & beverage: $948Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $88 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Galderma Laboratories, L.P. | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Octapharma USA, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $48 |
Products named: NEMLUVIO, TEZSPIRE, DUPIXENT, NEFFY, CUTAQUIG, Ohtuvayre, NUCALA, Xolair.
Industry payments across IN — which companies pay providers there.
